Immunology
3,062 studies361 in 7 days1,580 in 30 days
Filters
Latest
3,062 studies
- Editorial Note: Early Growth Response Gene-2 (Egr-2) Regulates the Development of B and T Cells
- B cell–macrophage interactions in colorectal cancer: state coupling, spatiotemporal remodeling, and therapeutic implications
- Killing with a purpose: harnessing immunological cell death in brain tumors
- Pathological mechanisms of the “lifestyle–immunometabolic–neuroendocrine” crosstalk network in ectopic fat deposition and skeletal muscle decline
- From CAF heterogeneity to immune modulation and therapeutic targeting: a subtype-based framework
- Interpreting immunoglobulin A evidence for the mucosal origins of rheumatoid arthritis autoimmunity
- 263 Effects of resorcinyl isoprenyl benzene derivative IPI201 on natural killer cell cytotoxicity and tumor cell viability in human colorectal adenocarcinoma cells
- From gut entry to hepatic defense: spatial and temporal coordination of host immunity to Listeria infection
- 860 mRNA-LNP-mediated immunomodulation for precision cancer vaccines and immunotherapy
- 902 Reprogrammed regulatory T cells as cytotoxic effectors drive anti-tumor immunity under bispecific T cell engager therapy
- Context-defined PHB2 states: an evidence-based framework for receptor-associated signaling, mitochondrial quality control and immune responses
- 133 In vitro comparison of the stability and biotransformation of sac-TMT and control antibody-drug conjugates in human plasma
- 849 A M2-like tumor-associated macrophage-targeted TLR7/8 agonist, UI-102, induces unique and durable antitumor immunity
- Safety and effectiveness of caplacizumab in pediatric patients with iTTP: real-world experience
- A fluorinated poly(amino acid) nanovaccine with spatiotemporally encoded innate priming and antigen cross-presentation for tumor immunotherapy
- 713 Vitamin B6-mediated lipid metabolic reprogramming as a strategy to restore antitumor T cell immunity in aging
- 658 Engineering NK cells to remodel tumor stroma
- 935 Designing polymers for the display of exogenous ligands to engage synthetic receptors on engineered T cells
- 36 Baseline systemic immune profiles predict prognosis and differential benefit from ipilimumab intensification in relapsed mesothelioma (Bio-IFCT-1501 MAPS2 trial)
- Case Report: Glofitamab and intrathecal rituximab combined with ICE chemotherapy for early isolated central nervous system relapse in pediatric Burkitt lymphoma: rapid clearance and successful bridging to autologous stem cell transplantation
- Oxeiptosis-associated transcriptional states, immune heterogeneity, and oxidative-stress susceptibility in triple-negative breast cancer
- Macrophage immunometabolic programming in pulmonary arterial hypertension: prioritizing TET2 and METTL3/m⁶A
- Case Report: Durable complete response to dual immune checkpoint blockade and EGFR inhibition in microsatellite-stable metastatic duodenal adenocarcinoma
- Plasmacytoid dendritic cells and M2 macrophages are associated with clinical outcomes in human papillomavirus–independent vulvar squamous cell carcinoma
- Ocular fluid biomarkers and anti-retinal autoantibodies in neovascular age-related macular degeneration: compartment-specific evidence and a provisional multidomain framework